Metronidazole derivatives and phenolic compounds as potential adjuvants against bacterial resistance mediated by the MepA efflux pump in the Staphylococcus aureus K2068 strain

Staphylococcus aureus is a Gram-positive pathogen that possesses resistance factors responsible for the occurrence of several diseases, including those affecting the airways and gastrointestinal tract, causing osteomyelitis and systemic infections that increase mortality rates. Metronidazole is a drug with antiparasitic and antibacterial activity, and the phenolic compounds eugenol, dihydroeugenol, guaiacol, and phenol exhibit several therapeutic activities, one of which is antibacterial. Thus, eight compounds were synthesized by linking metronidazole with the aforementioned compounds, forming substances designated AD1–AD8. This study aimed to investigate the adjuvant potential of compounds AD1–AD8 in enhancing the action of ciprofloxacin and ethidium bromide against the S. aureus K2068 strain, considering the possible involvement of MepA efflux pump modulation, as well as to evaluate the direct antibacterial activity of these compounds. Broth microdilution assays and molecular docking studies were performed to assess antibacterial activity and inhibition of the MepA efflux pump. Compounds AD1–AD8 reduced the minimum inhibitory concentration (MIC) of ciprofloxacin and ethidium bromide, with molecular docking results demonstrating a possible inhibition of the MepA efflux pump. Overall, substances AD1–AD8 were able to significantly potentiate the action of the antibiotic and ethidium bromide due to the probable blockade of the resistance mechanism. The obtained results indicate the potential of compounds AD1–AD8 as therapeutic adjuvants in combating efflux pump–mediated bacterial resistance.

Authors

Publication Details

Journal
Naunyn-Schmiedeberg s Archives of Pharmacology
Published
2026-11-20
DOI
https://doi.org/10.1007/s00210-026-06108-9
Primary Topic
Antimicrobial Resistance in Staphylococcus
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Metronidazole derivatives and phenolic compounds as potential adjuvants against bacterial resistance mediated by the MepA efflux pump in the Staphylococcus aureus K2068 strain

Janaína Esmeraldo Rocha, Cícera Datiane Morais Oliveira Tintino, Lucas Lopardi Franco, João Arthur de Oliveira Borges et al.
Naunyn-Schmiedeberg s Archives of Pharmacology
Antimicrobial Resistance in Staphylococcus
article

Metronidazole derivatives and phenolic compounds as potential adjuvants against bacterial resistance mediated by the MepA efflux pump in the Staphylococcus aureus K2068 strain

Janaína Esmeraldo Rocha, Cícera Datiane Morais Oliveira Tintino, Lucas Lopardi Franco, João Arthur de Oliveira Borges, José Bezerra de Araújo Neto, Henrique Douglas Melo Coutinho, Sheila Alves Gonçalves, Daniel Sampaio Alves, Ewerton Yago de Sousa Rodrigues, Cícera Laura Roque Paulo, Lucas dos Santos Sa, Francisco Ruan Moreira da Silva Santos, Francisco Nascimento Pereira Junior, Maria Karollyna do Nascimento Silva Leandro
article en

Abstract

Staphylococcus aureus is a Gram-positive pathogen that possesses resistance factors responsible for the occurrence of several diseases, including those affecting the airways and gastrointestinal tract, causing osteomyelitis and systemic infections that increase mortality rates. Metronidazole is a drug with antiparasitic and antibacterial activity, and the phenolic compounds eugenol, dihydroeugenol, guaiacol, and phenol exhibit several therapeutic activities, one of which is antibacterial. Thus, eight compounds were synthesized by linking metronidazole with the aforementioned compounds, forming substances designated AD1–AD8. This study aimed to investigate the adjuvant potential of compounds AD1–AD8 in enhancing the action of ciprofloxacin and ethidium bromide against the S. aureus K2068 strain, considering the possible involvement of MepA efflux pump modulation, as well as to evaluate the direct antibacterial activity of these compounds. Broth microdilution assays and molecular docking studies were performed to assess antibacterial activity and inhibition of the MepA efflux pump. Compounds AD1–AD8 reduced the minimum inhibitory concentration (MIC) of ciprofloxacin and ethidium bromide, with molecular docking results demonstrating a possible inhibition of the MepA efflux pump. Overall, substances AD1–AD8 were able to significantly potentiate the action of the antibiotic and ethidium bromide due to the probable blockade of the resistance mechanism. The obtained results indicate the potential of compounds AD1–AD8 as therapeutic adjuvants in combating efflux pump–mediated bacterial resistance.

Naunyn-Schmiedeberg s Archives of Pharmacology
Antimicrobial Resistance in Staphylococcus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon